Olivier Charmeil - Articles and news items


Sanofi Pasteur allies with SK Chemical Co. of South Korea on pneumococcal conjugate vaccine

Industry news / 19 March 2014 / Sanofi

A long-term strategic business collaboration to co-develop and commercialize an innovative vaccine against pneumococcal infection to address global public-health needs…


Menomune® is the first quadrivalent meningococcal vaccine prequalified by the WHO

Industry news, News / 3 September 2013 / Sanofi

Prequalification makes the vaccine eligible for purchase by United Nations Agencies…


Sanofi Pasteur to provide 1.7 billion doses of oral polio vaccine from 2013 to 2017 for polio eradication

Industry news, News / 24 April 2013 / Sanofi Pasteur

Company also expands injectable polio vaccine production capacity…


Hexyon/Hexacima 6-in-1 pediatric vaccine approved in Europe

Industry news, News / 22 April 2013 / Sanofi Pasteur

Hexyon/Hexacima is the only fully liquid, ready-to-use, 6-in-1 pediatric vaccine…


Sanofi and Transgene announce innovative long-term collaboration

Industry news, News / 25 March 2013 / Sanofi

Creation of a new state-of-the-art industrial platform at Genzyme’s unit in Lyon…


European Medicines Agency recommends approval of Hexyon/Hexacima 6-in-1 pediatric vaccine

Industry news, News / 22 February 2013 / Sanofi

The EMA recommended market approval for Sanofi Pasteur’s 6-in-1 pediatric vaccine…

Sanofi Pasteur

Sanofi Pasteur’s 6-in-1 pediatric vaccine Hexaxim™ receives positive opinion from EMA

Industry news, News / 22 June 2012 / Sanofi Pasteur

Sanofi Pasteur, announced that HexaximTM received a positive scientific opinion…

Japan chooses Sanofi Pasteur for first enhanced Inactivated Polio Vaccine

Industry news, News / 27 April 2012 / Sanofi

Approval of IMOVAX® POLIO by Japanese health authorities…

Sanofi Pasteur

Brazil Introduces Inactivated Polio Vaccine in National Immunization Program with Sanofi Pasteur Vaccine

Industry news, News / 18 January 2012 / Sanofi Pasteur

Brazil has chosen to introduce injectable polio vaccine in its national immunization program…

Sanofi Pasteur

Sanofi Pasteur’s Typhim Vi®, granted prequalification by the WHO

Industry news, News / 23 June 2011 / Sanofi Pasteur

Sanofi Pasteur, announced that the WHO has granted prequalification to its Typhim Vi® polysaccharide typhoid vaccine…

Intradermal microinjection

FDA licenses Sanofi Pasteur’s new influenza vaccine delivered by intradermal microinjection

Industry news, News / 10 May 2011 / Sanofi Pasteur

The FDA approved Sanofi Pasteur’s sBLA for licensure of Fluzone Intradermal…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...